Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.

Kirk, Allan D

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. [electronic resource] - Transplantation Oct 2005 - 1051-9 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

0041-1337

10.1097/01.tp.0000174341.49741.8f doi


Adult
Alemtuzumab
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--pharmacology
Chemokines--genetics
Creatine--blood
Female
Graft Rejection--metabolism
Guanidines--pharmacology
Humans
Immunosuppressive Agents--pharmacology
Kidney--cytology
Kidney Transplantation--immunology
Lymph Nodes--cytology
Lymphocyte Count
Lymphocyte Depletion
Male
Middle Aged
T-Lymphocytes--drug effects
Transcription, Genetic
Transplantation Tolerance--drug effects